Soo Kyung Lee

Soo Kyung Lee

Auto-generated profile, based on publicly available information

Soo Kyung Lee

Department of Physiology, Yonsei University Wonju College of Medicine, Wonju, Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
SLSun Chul Lee
Sun Chul Lee
SLSoo Kyung Lee
Soo Kyung Lee
HKHyun Kim
Hyun Kim
KPKyu-Sang Park
Kyu-Sang Park
The mitochondrial electron transport chain (ETC) serves as the main site of cellular energy production and a major source of reactive oxygen species (ROS) generation, which can contribute to the lipid peroxidation associated with ferroptosis. However, the critical roles of mitochondria in ferroptosis are still being debated, and the consequences for cell survival vary depending on different ferroptosis inducers or mitochondrial modulators. In the neuroblastoma clonal cells SH-SY5Y, we demonstrated that inhibition of mitochondrial Complex II by 2-thenoyltrifluoroacetone (TTFA) markedly suppressed RSL3-induced ferroptotic lipid peroxidation and cell death. RSL3, a known inhibitor of glutathione peroxidase 4 (GPX4), significantly increased the mitochondrial membrane potential and superoxide production while reducing ATP-linked oxygen consumption. Co-treatment with TTFA effectively attenuated RSL3-induced mitochondrial hyperpolarization, lowered mitochondrial ROS generation, and restored respiratory activities - particularly enhanced ATP-linked oxygen consumption and reduced proton leak. Consistently, TTFA restored ATP production suppressed by RSL3. In contrast, inhibition of Complex I by rotenone did not suppress superoxide production and lipid peroxidation induced by RSL3, although it provided some protection against RSL3-mediated cytotoxicity. These findings suggest that inhibition of Complex II confers protection against ferroptosis by maintaining mitochondrial redox balance and protecting mitochondrial energy metabolism. In addition, our results uncover a novel mitochondrial mechanism underlying RSL3-induced oxidative stress and ferroptosis that can be modulated through targeted regulation of the ETC.

13 July 2026 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
SCSuyeon Choi
Suyeon Choi
SOSeungjoo Oh
Seungjoo Oh
SKSoo-Jin Kim
Soo-Jin Kim
SLSoo Kyung Lee
Soo Kyung Lee
RDRANJAN DAS
RANJAN DAS
KPKyu-Sang Park
Kyu-Sang Park
Key Points: JNK3 was upregulated in kidney cortex tissues from patients with CKD with severe albuminuria, as well as in a mouse model of glomerulosclerosis. Selective inhibition of JNK3 effectively attenuated TGF- β –mediated podocyte injury and adriamycin-induced glomerulosclerosis. JMH021, highly potent and selective JNK3 inhibitor, showed significant protective effects against albuminuria and fibrosis in kidneys without toxicity. Background: Noncanonical TGF- β signaling plays a critical role in the progression of CKD, but the pathologic contributions of its downstream mitogen-activated protein kinases signaling such as extracellular signal–regulated kinase, p38 α , and c-Jun N -terminal kinase (JNK) remain unclear. We investigated whether JNK3, a JNK isoform traditionally considered neuron-specific isoform, contributes to TGF- β –mediated glomerular fibrosis and injury. Methods: JNK3 expression and function were examined using differentiated human podocytes, an adriamycin (ADR)-induced mouse model of glomerulosclerosis, and kidney cortex tissues from patients with CKD. Genetic and pharmacologic approaches were used to assess the role of JNK signaling in TGF- β –induced cellular responses and glomerular injury. Results: Kidney cortex tissues from patients with CKD with severe albuminuria and ADR-treated mice exhibited increased JNK3 expression and enhanced c-Jun phosphorylation, indicating activation of JNK signaling in association with glomerular injury. In human podocytes, genetic or pharmacologic inhibition of JNK suppressed TGF- β –induced activation of Smad2/3 and extracellular signal–regulated kinase signaling, reduced endogenous TGF- β expression, and attenuated profibrotic phenotype changes. JNK inhibition also decreased reactive oxygen species production, preserved expression of podocyte structural proteins, including synaptopodin, podocin, and nephrin, and reduced albumin permeability. Among JNK isoforms, JNK3 knockdown conferred the greatest protection against TGF- β –induced loss of epithelial phenotype and fibrotic responses. We used JMH021, a selective imidazole-based JNK3 inhibitor, which more effectively prevented TGF- β –induced fibrosis and disruption of podocyte barrier function than the pan-JNK inhibitor SP600125. In vivo , JMH021 significantly improved ADR-induced glomerulosclerosis, foot process effacement, albuminuria, and kidney dysfunction, while avoiding the hepatotoxicity observed with SP600125. Conclusions: These findings suggest that selective JNK3 inhibition effectively attenuates TGF- β –driven glomerular fibrosis and proteinuria without serious complications.

18 November 2026 in Molecules and Cells
Verified
Journal Article
Open access
SKSoo-Jin Kim
Soo-Jin Kim
CNCarlos Noriega-Polo
Carlos Noriega-Polo
SCSuyeon Choi
Suyeon Choi
SLSoo Kyung Lee
Soo Kyung Lee
SOSeungjoo Oh
Seungjoo Oh
KPKyu-Sang Park
Kyu-Sang Park